Trial intelligence / Profile preview

Chronic SQ BNP in Preclinical Diastolic Dysfunction

NCT00405548Phase 2Completed

Sponsor
Mayo Clinic
Start
Mar 2008
Primary completion
Apr 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of nesiritide in left ventricular diastolic dysfunction (LVDD), sponsored by Mayo Clinic. Started Mar 2008; status: completed.

02

Drugs

nesiritide
03

Conditions

left ventricular diastolic dysfunction (LVDD)

Beyond the preview

Go deeper on NCT00405548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00405548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call